Concurrent chemoradiotherapy with weekly versus three-weekly cisplatin in locally advanced head and neck squamous cell carcinoma
In Cochrane Database of Systematic Review
Contributor(s): Kannan S | Gupta T | Nair S | drshiva78in@gmail.com | Shivakumar T.
Material type:
ArticleSeries: Issues 1.Publisher: 2014Description: CD010906.Subject(s): Squamous cell carcinoma | Head and neck cancer | Cisplatin | Chemoradiotherapy | DDC classification:
In:
Cochrane Database of Systematic ReviewSummary: This is the protocol for a review and there is no abstract. The objectives are as follows:
Primary objective
To assess the efficacy of a weekly cisplatin regimen compared to a three-weekly regimen, given with curative intent to treat locally advanced HNSCC, in terms of overall survival (at five years).
Secondary objective
To assess the distant metastasis-free survival (at two years), disease-free survival (at two years) and the toxicity profile of the two regimens.
| Item type | Current location | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|
Articles
|
Tata Memorial Hospital | Available | AR14562 |
This is the protocol for a review and there is no abstract. The objectives are as follows:
Primary objective
To assess the efficacy of a weekly cisplatin regimen compared to a three-weekly regimen, given with curative intent to treat locally advanced HNSCC, in terms of overall survival (at five years).
Secondary objective
To assess the distant metastasis-free survival (at two years), disease-free survival (at two years) and the toxicity profile of the two regimens.
There are no comments for this item.